However it is of worth, mentioning that recombinant Para-thyroid hormone
besides its more effectiveness is prescribed very less in Pakistan
because of its increased cost of therapy and is not easily available
around the country, whereas bisphosphonates with comparative less
effectiveness is prescribed more rapidly due to affordable cost of the
entire therapy and easy availability. Due to the developing status of
Pakistan, it's unable to formulate recombinant human Para-thyroid
hormone subcutaneous injection and hence import the drug.